PATENT CLAIM ANALYSIS

Application Number: 15985861
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "006500"]

Abstract:
The present invention relates to a certain DPP-4 inhibitor for use in cardio- and/or renoprotective therapy, including in patients at high vascular risk.

Claim (Index 15):
The method of  claim 1 , wherein the one or more other active agents is selected from the group consisting of other antidiabetic substances, active substances that lower the blood sugar level, active substances that lower the lipid level in the blood, active substances that raise the HDL level in the blood, active substances that lower blood pressure, active substances that are indicated in the treatment of atherosclerosis or obesity, and/or active substances which are indicated in the treatment or prevention of major CV events and antiplatelet agents and/or anticoagulants.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 93.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15616974', '14928048', '15354053', '14633489', '13295174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7987076151573809
- 35 USC 102 Novelty (BERT): 0.57594027344769
- Combined Prediction Score: 0.7764308809864119
- Mean Citation Score: 402.033366
- Max Citation Score: 576.928
- Similarity Product: 361.1316456947326

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test